William Harvey Research Institute, Clinical Pharmacology, Queen Mary University of London, London, EC1M 6BQ, UK.
UCL Institute of Ophthalmology, University College London, London, EC1V 9EL, UK.
Nat Commun. 2020 Feb 7;11(1):778. doi: 10.1038/s41467-020-14499-3.
Age-related macular degeneration (AMD) is a leading cause of blindness. Genetic variants at the chromosome 1q31.3 encompassing the complement factor H (CFH, FH) and CFH related genes (CFHR1-5) are major determinants of AMD susceptibility, but their molecular consequences remain unclear. Here we demonstrate that FHR-4 plays a prominent role in AMD pathogenesis. We show that systemic FHR-4 levels are elevated in AMD (P-value = 7.1 × 10), whereas no difference is seen for FH. Furthermore, FHR-4 accumulates in the choriocapillaris, Bruch's membrane and drusen, and can compete with FH/FHL-1 for C3b binding, preventing FI-mediated C3b cleavage. Critically, the protective allele of the strongest AMD-associated CFH locus variant rs10922109 has the highest association with reduced FHR-4 levels (P-value = 2.2 × 10), independently of the AMD-protective CFHR1-3 deletion, and even in those individuals that carry the high-risk allele of rs1061170 (Y402H). Our findings identify FHR-4 as a key molecular player contributing to complement dysregulation in AMD.
年龄相关性黄斑变性(AMD)是导致失明的主要原因之一。位于染色体 1q31.3 上的基因变异,包括补体因子 H(CFH,FH)和 CFH 相关基因(CFHR1-5),是 AMD 易感性的主要决定因素,但它们的分子后果仍不清楚。在这里,我们证明 FHR-4 在 AMD 的发病机制中起着重要作用。我们表明,AMD 患者的全身 FHR-4 水平升高(P 值=7.1×10),而 FH 则没有差异。此外,FHR-4 在脉络膜毛细血管、Bruch 膜和玻璃膜疣中积累,并且可以与 FH/FHL-1 竞争 C3b 结合,从而阻止 FI 介导的 C3b 裂解。至关重要的是,与最强的 AMD 相关 CFH 基因座变异 rs10922109 相关的保护性等位基因与降低的 FHR-4 水平具有最高的相关性(P 值=2.2×10),这与 AMD 保护性 CFHR1-3 缺失无关,甚至与携带 rs1061170(Y402H)高风险等位基因的个体也无关。我们的研究结果表明,FHR-4 是导致 AMD 中补体失调的关键分子。